Results and Discussions

cytC Encapsulation and Release Studies
For this study, a new type of MSNs featuring a cuboidal-like geometry (90 × 43 nm 2 ) was synthesized ( Figure 1b) . [37] The nitrogen adsorption-desorption isotherms of MSNs exhibited the characteristic type IV isotherms [38] with a BrunauerEmmett-Teller (BET) surface area of 506 m 2 g −1 ( Figure 1c ). The pore size distribution was found to be 10 ± 1 nm. cytC (geometric size 2.6 × 3.2 × 3.3 nm 3 ) is a small redox protein that is present in the inner membrane of mitochondria and induces apoptosis when released into the cytosol. [39] The pore dimensions of MSNs are sufficiently large to accommodate cytC and the open disk-shaped mesostructure renders the encapsulation of cytC very efficient. Within less than 5 min more than 95% of cytochrome-c (cytC) was encapsulated into Protein delivery into the cytosol of cells is a challenging topic in the field of nanomedicine, because cellular uptake and endosomal escape are typically inefficient, hampering clinical applications. In this contribution cuboidal mesoporous silica nanoparticles (MSNs) containing disk-shaped cavities with a large pore diameter (10 nm) are studied as a protein delivery vehicle using cytochrome-c (cytC) as a model membrane-impermeable protein. To ensure colloidal stability, the MSNs are coated with a fusogenic lipid bilayer (LB) and cellular uptake is induced by a complementary pair of coiled-coil (CC) lipopeptides. Coiled-coil induced membrane fusion leads to the efficient cytosolic delivery of cytC and triggers apoptosis of cells. Delivery of these LB coated MSNs in the presence of various endocytosis inhibitors strongly suggests that membrane fusion is the dominant mechanism of cellular uptake. This method is potentially a universal way for the efficient delivery of any type of inorganic nanoparticle or protein into cells mediated by CC induced membrane fusion.
Introduction
Intracellular protein delivery holds promise for a range of biomedical applications, [1] such as cancer therapy, [2, 3] vaccination, and enzyme based therapeutics. [4] However, therapeutic proteins are susceptible to proteolysis and denaturation, limiting their efficacy in the body. [5, 6] To solve the delivery problem, protein delivery systems based on for instance polymeric nanoparticles, [7] hydrogels, [8, 9] or lipid-based nanoparticles [10, 11] have been developed. Also mesoporous silica nanoparticles (MSNs) have been studied as carriers for a variety of biomolecules including anticancer drugs, oligonucleotides, and proteins. [2, [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] However, most MSNs used in drug delivery studies to date typically have pores with diameters up to 4 nm, thereby limiting their use as efficient carriers for high the mesoporous silica nanoparticles (MSNs/cytC). The maximum cytC loading capacity of these cuboidal MSNs was determined to be 470 µg mg −1 MSNs (Figure 2a, black curve) . The zeta-potential of MSNs/cytC also changed by increasing the concentration of cytC (Figure 2a , red curve), reaching almost neutrality at saturating concentrations of cytC. At cytC:MSNs weight ratios of 1:8 or 1:4 the encapsulation efficiency (EE%) was quantitative, revealing the excellent protein encapsulation potential of these large-pore MSNs. Compared to native cytC, the encapsulated cytC in the MSNs revealed a slight broadening of the adsorption peak in the UV-Vis spectrum, but no blue shift was observed, suggesting that the interaction between the protein and pore surface did not change the structure of cytC ( Figure S1a , Supporting Information). [40] Since cytC has a positive charge at pH 7.4 its adsorption is mainly driven by electrostatic interactions with the negatively charged silanol groups on the surface of MSNs. [41, 42] Therefore, we studied the influence of ionic strength on the release profile of cytC. At high ionic strength (270 × 10 −3 m), 70.4% of cytC was released from MSNs/cytC which decreased to only 16.8% in low ionic strength (12 × 10 −3 m) buffer revealing the electrostatic nature of protein binding ( Figure S1 , Supporting Information). Thus, cytC can be loaded with high efficiency into MSNs at low ionic strength and subsequently released at conditions of high ionic strength (e.g., inside cells).
However, the decreased surface charge of MSNs upon cytC loading as evidenced by the near neutral zeta-potential induced aggregation of the nanoparticles. To increase their colloidal stability MSNs/cytC were therefore decorated with a lipid bilayer. After introduction of a fusogenic lipid bilayer composed of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoylsn-glycero-3-phosphoethanolamine (DOPE), and cholesterol (2:1:1 molar ratio) [43] [44] [45] the observed hydrodynamic diameter by dynamic light scattering of the nanoparticles was ≈230 nm (polydispersity index = 0.251) (Figure 2b ). After loading the MSNs with cytC, the zeta-potential shifted from −28.0 to −11.6 mV. Application of the lipid bilayer onto the exterior surface of these particles resulted in a more negative zeta-potential (−20.5 mV) ( Figure 2c ). As a result the lipid coated nanoparticles were colloidal stable for at least one week. The presence of the lipid bilayer also reduced the premature release of cytC by a factor of ≈1.6 as the lipid bilayer acts as a physical barrier [46] thereby retaining the protein better within the MSNs (Figure 2d ).
Intracellular Delivery of cytC
Previously, we reported that a pair of complementary lipopeptides (i.e., CP 4 E 4 /CP 4 K 4 ) designed to form coiled-coils was able to mediate the targeted fusion of membranes between liposomes and cells. [27, 47] So far, this approach was used to deliver low molecular weight dyes and drugs into the cytosol and nucleus of live cells. To study the scope of this synthetic fusion system, we now were interested to study whether coiled-coil mediated fusion could be used to enhance the intracellular delivery of inorganic nanoparticles like MSNs. Typically, MSNs or lipid bilayer coated MSNs are taken up by endocytosis, [14, 46, 48, 49] which can be detrimental to the cargo.
By employing coiled-coil mediated delivery, the cellular uptake mechanism might be shifted from endocytosis to a direct cytosolic entry via membrane fusion. In order to enhance the intracellular delivery of MSNs/cytC, the nanoparticles were coated with a fusogenic lipid bilayer containing 1 mol% CP 4 E 4 (MSNs/cytC@CPE-LBs). To induce nanoparticle uptake via membrane fusion, cells were pretreated with CP 4 K 4 [29] and subsequently MSNs/cytC@CPE-LBs were added to the medium. Lipopeptides and lipid bilayer coated MSNs with or without CP 4 E 4 were well tolerated by HeLa cells as no signs of toxicity were observed ( Figure S2 , Supporting Information). Confocal microscopy imaging revealed that the cytosol became fluorescent within 30 min, indicative of the efficient delivery of Atto488-labeled cytC inside the cytosol (Figure 3a) . By contrast, when one or both of the lipopeptides were omitted, and thus coiled-coil mediated fusion cannot occur, only limited cellular uptake was observed ( Figure S3 , Supporting Information). The intracellular location of the MSNs upon CC mediated delivery was further investigated by transmission electron microscopy (TEM). It showed that a fraction of the MSNs was outside of the cell, some were entering into the cytoplasm while the majority already appeared inside the cytosol (Figure 3d,e) .
Importantly, the MSNs appeared not to be localized in endosomes or lysosomes, but were found in the cytosol. From the TEM image it seemed that the MSNs were aggregated (Figure 3e delivery into the cells, the MSNs lose their lipid bilayers and it is well-known that bare MSNs have a tendency to aggregate. In comparison, the uptake efficiency of bare MSNs into cells is low ( Figure S3c , Supporting Information). More importantly, in the control experiment bare MSNs were located in early endosomal compartments as evidenced by the presence of a membrane bilayer ( Figure S4 , Supporting Information). These results show that CC driven membrane fusion enhances the cellular uptake of these nanoparticles.
Endocytosis and Micropinocytosis Inhibitors Marginally Affect Delivery
To investigate the cellular uptake pathway, we repeated the lipid bilayer coated MSNs delivery in the presence of several well-known inhibitors using flow cytometry measurements (FACS) and confocal microscopy imaging. [27, [50] [51] [52] [53] [54] In this study, wortmannin (Wor) was used as a micropinocytosis inhibitor as it blocks PI3-kinase, [50, 52, 55, 56] while genistein (Gen) inhibits tyrosine-phosphorylation of Cav 1 and caveolin-dependent endocytosis. [57] [58] [59] Furthermore, chlorpromazine (Chl) was used as it blocks clathrin-dependent endocytosis, [51, 60, 61] and microtubule formation was inhibited by nocodazole (Noc). Uptake studies in the presence of these inhibitors give insight in the intracellular trafficking and internalization mechanisms involved in the uptake of the lipid bilayer coated MSNs. [50] [51] [52] [53] [54] Finally, as endocytosis of nanoparticles is an energy-dependent process, sodium azide (NaN 3 ) was used to deplete the energy demands for endocytosis and restrict metabolic activity. [62, 63] FACS analysis revealed that Gen, Wor, and Noc had no adverse effect on the delivery of fluorescently labeled cytC (Figure 4a) , whereas in the presence of Chl and NaN 3 , uptake of nanoparticles containing cytC was slightly lowered to 90% as compared to the initial experiment in the absence of inhibitors. To further study the role of CC formation on the mechanism of cellular uptake, we omitted the CP 4 K 4 pretreatment of HeLa cells in control experiments. Without inhibitors, the MSNs/ cytC uptake was less than 60% (Figure 4b, red column) . In the presence of Chl or NaN 3 , the uptake of lipid bilayer coated MSNs was sharply reduced to 10% (Figure 4b , dark blue and blue columns). This clearly indicates that in this control experiment the nanoparticles are most likely taken up by a clathrindependent endocytosis pathway. Taken together these inhibition studies strongly indicated that the dominant pathway for CC mediated MSN delivery is most likely via membrane fusion between the lipid bilayer coated MSNs and the cell membrane. By contrast, when CC mediated delivery cannot occur due to the absence of the lipopeptides, the dominant and less efficient route of cellular uptake is via endocytosis.
Cell Apoptosis Induced by cytC after Delivery
It is well-known that an increase in cytC concentration in the cytosol triggers caspase activation, [64] [65] [66] ultimately resulting in apoptosis of the cell. [39, 67] Therefore, the amount of apoptosis as quantified by caspase activity can be used as a tool to confirm the actual delivery of cytC in the cytosol of cells. (Figure 5b,c) . In summary, coiled-coil mediated membrane fusion enhanced the observed level of apoptosis, due to the increased uptake and release of cytC into the cytosol of cells. In control experiments where one or both of the lipopeptides were omitted only minimal levels of apoptosis (<10%) were observed, revealing that coiled-coil mediated delivery of MSNs@ LBs is more efficient when compared to delivery via endocytic pathways (Figure 5d-f ).
Conclusions
Direct cytosolic delivery of cytC encapsulated MSNs decorated with a fusogenic lipid bilayer was achieved by targeted coiled-coil mediated membrane fusion with the cells while the uptake via endocytosis was minimized as shown by the inhibition cell uptake study. The uptake pathway and localization of MSNs/cytC in HeLa cells were confirmed by TEM and confocal imaging, and the release of functional cytC was demonstrated by its ability to trigger enhanced levels of apoptosis. We believe that our coiled-coil-based membrane fusion system is suitable for the delivery of a wide range of proteins or high molecular weight compounds as long as these can be encapsulated in the pores of the MSNs. It is envisaged that this method is also suitable for the delivery of any (in)organic nanoparticles as long as it can be encapsulated in or decorated with a fusogenic lipid bilayer carrying the coiled coil peptide at its interface. Therefore, this method of delivery may have applications in the field of biomedicine and diagnostics. 
